Indication: It is suitable for infections caused by microorganisms that are sensitive to clarithromycin: 1. Lower respiratory tract infections: such as bronchitis, pneumonia, etc.; 2. Upper respiratory tract infections: such as pharyngitis, sinusitis, etc.; 3. Mild to moderate infections of the skin and soft tissues: such as folliculitis, cellulitis, erysipelas, etc.

Indication: It is suitable for infections caused by microorganisms that are sensitive to clarithromycin: 1. Lower respiratory tract infections: such as bronchitis, pneumonia, etc.; 2. Upper respiratory tract infections: such as pharyngitis, sinusitis, etc.; 3. Mild to moderate infections of the skin and soft tissues: such as folliculitis, cellulitis, erysipelas, etc.

Indication: It is suitable for the following infections caused by clarithromycin-sensitive bacteria: 1. Nasopharyngeal infections: tonsillitis, pharyngitis, sinusitis. 2. Lower respiratory tract infections: acute bronchitis, acute exacerbation of chronic bronchitis and pneumonia. 3. Skin and soft tissue infections: impetigo, erysipelas, folliculitis, furunculosis and wound infections. 4. Acute otitis media, pneumonia caused by Mycoplasma pneumonia, urethritis and cervicitis caused by Chlamydia trachomatis, etc. 5. It is also used for Legionella infection, or combined with other drugs for the treatment of Mycobacterium avium infection and Helicobacter pylori infection.

Indication: It is suitable for the following infections caused by clarithromycin-sensitive bacteria: 1. Nasopharyngeal infections: tonsillitis, pharyngitis, sinusitis. 2. Lower respiratory tract infections: acute bronchitis, acute exacerbation of chronic bronchitis and pneumonia. 3. Skin and soft tissue infections: impetigo, erysipelas, folliculitis, furunculosis and wound infections. 4. Acute otitis media, pneumonia caused by Mycoplasma pneumonia, urethritis and cervicitis caused by Chlamydia trachomatis, etc. 5. It is also used for Legionella infection, or combined with other drugs for the treatment of Mycobacterium avium infection and Helicobacter pylori infection.

Indication: It is suitable for infections caused by microorganisms that are sensitive to clarithromycin: 1. Lower respiratory tract infections: such as bronchitis, pneumonia, etc.; 2. Upper respiratory tract infections: such as pharyngitis, sinusitis, etc.; 3. Mild to moderate infections of the skin and soft tissues: such as folliculitis, cellulitis, erysipelas, etc.

Indication: It is suitable for infections caused by microorganisms that are sensitive to clarithromycin: 1. Lower respiratory tract infections: such as bronchitis, pneumonia, etc.; 2. Upper respiratory tract infections: such as pharyngitis, sinusitis, etc.; 3. Mild to moderate infections of the skin and soft tissues: such as folliculitis, cellulitis, erysipelas, etc.

Indication: It is suitable for infections caused by microorganisms that are sensitive to clarithromycin: 1. Lower respiratory tract infections: such as bronchitis, pneumonia, etc.; 2. Upper respiratory tract infections: such as pharyngitis, sinusitis, etc.; 3. Mild to moderate infections of the skin and soft tissues: such as folliculitis, cellulitis, erysipelas, etc.

Indication: Penicillin V potassium is suitable for mild and moderate infections caused by penicillin-sensitive strains, including tonsillitis, pharyngitis, scarlet fever, erysipelas, etc. caused by streptococci; bronchitis, pneumonia, otitis media, sinusitis caused by pneumococci; and skin and soft tissue infections caused by sensitive staphylococci, etc. Penicillin V potassium can also be used as a preventive drug for recurrent rheumatic fever and infective endocarditis, and can also be used for spirochetal infections.

Indication: To reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin V potassium and other antibacterial drugs, penicillin V potassium should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Penicillin V potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin G-sensitive microorganisms. Therapy should be guided by bacteriologic studies (including sensitivity tests) and by clinical response. NOTE: Severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin V during the acute stage. Indicated surgical procedures should be performed. The following infections will usually respond to adequate dosage of penicillin V. Streptococcal Infections (without bacteremia) Mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. NOTE: Streptococci in groups A, C, G, H, L, and M are very sensitive to penicillin. Other groups, including group D (enterococcus), are resistant. Pneumococcal Infections Mild to moderately severe infections of the respiratory tract. Staphylococcal infectionsen dash penicillin G-sensitive Mild infections of the skin and soft tissues. NOTE: Reports indicate an increasing number of strains of staphylococci resistant to penicillin G, emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections. Fusospirochetosis (Vincent’s gingivitis and pharyngitis) Mild to moderately severe infections of the oropharynx usually respond to therapy with oral penicillin. NOTE: Necessary dental care should be accomplished in infections involving the gum tissue. Medical conditions in which oral penicillin therapy is indicated as prophylaxis: For the prevention of recurrence following rheumatic fever and/or chorea: Prophylaxis with oral penicillin on a continuing basis has proven effective in preventing recurrence of these conditions. Although no controlled clinical efficacy studies have been conducted, penicillin V has been suggested by the American Heart Association and the American Dental Association for use as an oral regimen for prophylaxis against bacterial endocarditis in patients who have congenital heart disease or rheumatic or other acquired valvular heart disease when they undergo dental procedures and surgical procedures of the upper respiratory tract 1 alpha NOTE: When selecting antibiotics for the prevention of bacterial endocarditis, the physician or dentist should read the full joint statement of the American Heart Association and the American Dental Association 1